Global Digital Pathology Market Trends, Forecast Report 2025-2037
Digital Pathology Market size is projected to grow from USD 1.27 billion to USD 5.14 billion, witnessing a CAGR of over 11.3% during the forecast timeline, between 2025 and 2037. In the year 2025, the industry size of digital pathology is assessed at USD 1.39 billion.
The market growth can be attributed primarily to rising prevalence of cancer worldwide. Globally, cancer causes more than 10 million deaths each year, according to the World Health Organization. Digital pathology subfield focuses on managing data collected from digitized specimen slides using information generated from those slides. Through the use of computer-based technology, digital pathology utilizes virtual microscopy. A computer monitor can be used to view, share, manage, analyze and interpret glass slides transformed into digital slides.
Moreover, growing elderly population, the rapid development in advance pathology technology, growing number of healthcare organizations adopting digital imagining, introduction of hybrid models along with rising healthcare spending is expected to drive the global market growth. According to the Centers for Medicare & Medicaid Services, US healthcare spending accounted for USD 4.1 trillion in 2020, representing 19.7% of the nation's GDP.
Digital Pathology Sector: Growth Drivers and Challenges
Growth Drivers
- Surge in Incidence of Cardiovascular Diseases (CVDs) Around the World- As per the data from World Health Organization, a global estimate of 17.9 million people died from cardiovascular diseases in 2019, accounting for 32% of all deaths.
- As chronic conditions become more prevalent, digital pathology is expected to become more essential to treat patients, improve diagnostic performance, and reduce the high cost of conventional diagnostics. Chronic diseases are associated with high mortality rates. Cardiovascular Diseases (CVDs) are highly prevalent, which makes advanced diagnostic and imaging procedures necessary.
- Increasing Number of Laboratory Tests Performed Worldwide- According to the Centers for Disease Control and Prevention, a total of 14 billion laboratory tests are ordered each year. Lab test results are crucial to 70% of medical decisions, demonstrating the vital role clinical laboratories play in healthcare.
- Rise in the Number of Drug Discovery Trials - According to research that was conducted, over 13% of clinical drug trials have been approved by the FDA in 2018, an increase from 2017
- Increase in Exports of Automatic Data Processing Machines - The International Trade Center (Trademap) reports that the value of exports of automatic data processing machines in China in 2021 was USD 8,506,449 thousand, an increase from USD 7,397,894 thousand the previous year.
- Rapid Adoption of AI Tools in Healthcare- For instance, the demand for artificial intelligence (AI)-based solutions is anticipated to rise by over 48% among healthcare organizations.
Challenges
- Higher Maintenance Cost
- Un-Availability Of Skilled Manpower
- High Cost Associated With Integration And Implementation Of Hardware & Software
Digital Pathology Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
11.3% |
|
Base Year Market Size (2024) |
USD 1.27 billion |
|
Forecast Year Market Size (2037) |
USD 5.14 billion |
|
Regional Scope |
|
Digital Pathology Segmentation
End-user (Hospitals, Clinics, Diagnostic & Private Laboratories, Research Centers)
The global digital pathology market is segmented and analyzed for demand and supply by end-user into hospitals, clinics, diagnostic & private laboratories and research centers. Among these segments, the hospital segment is anticipated to capture the largest market size in the global digital pathology market owing to the increasing adoption of digital imaging and scanning methodology in hospitals for quick treatment of patients. Furthermore, the increasing government initiatives to support medical hospitals along with the growing number of hospital visits across the world are expected to augment segment growth over the forecast period. For instance, nearly 800 outpatient visits occurred in United States in the year 2020.
Our in-depth analysis of the global market includes the following segments:
|
By Component Type |
|
|
By Application |
|
|
By End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportDigital Pathology Industry - Regional Synopsis
The market in North America is expected to dominate largest share by the end of 2037, backed by rising geriatric population in the region. It was estimated that the U.S. population aged above 65 years was recorded to be 54 million in the year 2019. Moreover, the increasing R&D investments, continuous government support for development in IT healthcare, growing acceptance of digital imaging, rising awareness of the early diagnosis of diseases among population and presence of key manufacturers in the region are expected to impel the market revenue.
Companies Dominating the Digital Pathology Landscape
- ContextVision AB
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Leica Biosystems Nussloch GmbH
- GE Healthcare
- Ventana Medical Systems Inc.
- Hamamatsu Photonics K.K.
- Apollo Enterprise Imaging Corporation
- Xifin Inc.
- Definiens AG.
- Inspirata, Inc.
- 3DHISTECH Ltd.
In the News
- With this latest version of Apollo Enterprise Imaging Corporation's imaging solution, arcc, users will be able to manage more information simultaneously, as well as select and display images in new ways.
- SpIntellx has joined Inspirata Inc., growing ecosystem of partners to further strengthen and diversify its cancer informatics and digital pathology solutions.
Author Credits: Radhika Pawar
- Report ID: 1185
- Published Date: Jan 17, 2025
- Report Format: PDF, PPT
